Idorsia's development compounds target a number of different diseases.

Fabry disease

Fabry disease

Fabry disease is a rare inherited disorder in which a particular lipid (a fat-like substance) can’t be broken down by the body, leading to its build-up in the cells of the body organs.

Insomnia

Insomnia

Insomnia is defined as a combination of both dissatisfaction with sleep and a significant negative impact on daytime functioning. Insomnia is, worldwide, the most commonly reported sleeping disorder.

Resistant Hypertension Management

Resistant Hypertension Management

High blood pressure (also known as hypertension) is one of the most common medical conditions and its prevalence continues to rise. If someone’s high blood pressure can’t be lowered, despite treatment with a combination of three anti-hypertensive drugs of different categories (including a diuretic), they may have resistant hypertension.

Cerebral vasospasm associated with aSAH

Cerebral vasospasm associated with aSAH

Aneurysmal subarachnoid hemorrhage (aSAH) is a sudden life-threatening bleeding occurring in the subarachnoid space. In about one third of aSAH patients, a worsening of their condition may occur due to delayed cerebral vasospasm.

Systemic lupus erythematosus

Systemic lupus erythematosus

Systemic lupus erythematosus (SLE), the most common form of Lupus, is an autoimmune disease which can affect the skin, joints, kidneys, brain and other organs.